Adar1-Capital-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
198
Total Value
523731625
Accession Number
0001940272-25-000003
Form Type
13F-HR
Manager Name
Adar1-Capital-Management
Data Enrichment
82% identified
163 identified35 unidentified

Holdings

198 positions
Manager:
Search and click to pin securities to the top
Page 10 of 10
62459M206
Shares:19.1K
Value:$35.0K
LEAP THERAPEUTICS, INC.
Shares:111.0K
Value:$33.9K
G1000R127
Shares:505.1K
Value:$33.6K
CytomX Therapeutics, Inc.
Shares:47.0K
Value:$29.9K
G0544A145
Shares:215.0K
Value:$29.8K
Xilio Therapeutics, Inc.
Shares:40.0K
Value:$29.0K
PepGen Inc.
Shares:20.4K
Value:$28.6K
ProQR Therapeutics N.V.
Shares:20.4K
Value:$27.1K
Neumora Therapeutics, Inc.
Shares:26.1K
Value:$26.1K
Mereo BioPharma Group plc
Shares:10.0K
Value:$22.5K
Cellectar Biosciences, Inc.
Shares:40.2K
Value:$12.7K
Rallybio Corp
Shares:13.4K
Value:$8.8K
G5212E113
Shares:30.0K
Value:$8.4K
462837121
Shares:25.0K
Value:$7.5K
Connect Biopharma Holdings Ltd
Shares:10.3K
Value:$5.7K
G3034H141
Shares:13.1K
Value:$2.4K
462837113
Shares:25.0K
Value:$800
G3034H125
Shares:18.0K
Value:$695